Crowdonomics
WatchlistPortfolio
All companies
Testasy, Inc. logo

Testasy, Inc.

Operating

Software & AI · Boston, MA

Visit website

Testasy, doing business as illumicell AI, develops an AI-powered diagnostic platform that uses imaging and computer vision to analyze semen quality, measuring sperm concentration, motility and morphology within minutes. It is aimed at fertility clinics, urology and OB-GYN practices, and research labs, as a replacement for slow, inconsistent manual analysis.

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$100,000
Across 1 round since 2025

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$0
−$216K
2023
$0
−$1.1M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
-$216,286
-$1,053,240
Net income
-$216,286
-$1,053,240
Taxes paid
$0
$0
Balance sheet
Cash
$358,494
$460,791
Accounts receivable
$0
$0
Total assets
$358,494
$460,791
Short-term debt
$4,780
$45,317
Long-term debt
$0
$0
Total liabilities
$4,780
$45,317
Other
Headcount
—
17

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · CrowdSAFE · Dec 2025Closedvia ICON CAPITAL GROUP, LLC
Raised $100K / $1.2M

Team

3 people
Michel Bielecki
Chief Executive Officer
Jeyla Sadikhova
Director
William Swenson
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UMay 22, 20260002093263-26-000009
    EDGAR
  • Form C/AApr 15, 20260002093263-26-000006
    EDGAR
  • Form C/AMar 6, 20260002093263-26-000005
    EDGAR
  • Form C/AFeb 25, 20260002093263-26-000002
    EDGAR
  • Form C/AFeb 5, 20260002093263-26-000001
    EDGAR
  • Form CDec 29, 20250002093263-25-000001
    EDGAR
Source: SEC EDGARCIK 0002093263DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.